Ana Santos Almeida

Ana Santos Almeida

Auto-generated profile, based on publicly available information

Ana Santos Almeida

Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2017 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
DÖDaniel Öhlund
Daniel Öhlund
AHAbram Handly-Santana
Abram Handly-Santana
GBGiulia Biffi
Giulia Biffi
EEEla Elyada
Ela Elyada
AAAna S. Almeida
Ana S. Almeida
DTDavid A. Tuveson
David A. Tuveson
Pancreatic stellate cells (PSCs) differentiate into cancer-associated fibroblasts (CAFs) that produce desmoplastic stroma, thereby modulating disease progression and therapeutic response in pancreatic ductal adenocarcinoma (PDA). However, it is unknown whether CAFs uniformly carry out these tasks or if subtypes of CAFs with distinct phenotypes in PDA exist. We identified a CAF subpopulation with elevated expression of α-smooth muscle actin (αSMA) located immediately adjacent to neoplastic cells in mouse and human PDA tissue. We recapitulated this finding in co-cultures of murine PSCs and PDA organoids, and demonstrated that organoid-activated CAFs produced desmoplastic stroma. The co-cultures showed cooperative interactions and revealed another distinct subpopulation of CAFs, located more distantly from neoplastic cells, which lacked elevated αSMA expression and instead secreted IL6 and additional inflammatory mediators. These findings were corroborated in mouse and human PDA tissue, providing direct evidence for CAF heterogeneity in PDA tumor biology with implications for disease etiology and therapeutic development.

19 October 2016 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
JPJuwon Park
Juwon Park
RWRobert W. Wysocki
Robert W. Wysocki
ZAZohreh Amoozgar
Zohreh Amoozgar
LMLaura Maiorino
Laura Maiorino
MFMiriam R. Fein
Miriam R. Fein
MEMikala Egeblad
Mikala Egeblad
Treatment with DNase I–coated nanoparticles prevents metastasis by targeting neutrophil extracellular traps induced by cancer cells in a mouse model.

2 September 2021 in Cancer Cell
Verified
Journal Article
Closed access
LSLijuan Sun
Lijuan Sun
TKTim Kees
Tim Kees
AAAna Santos Almeida
Ana Santos Almeida
BLBodu Liu
Bodu Liu
XHXue-Yan He
Xue-Yan He
MEMikala Egeblad
Mikala Egeblad

29 May 2014 in BMC Biology
Verified
Journal Article
Open access
PDF file
LLLeticia Miranda Santos Lery
Leticia Miranda Santos Lery
LFLionel Frangeul
Lionel Frangeul
ATAnna Tomas
Anna Tomas
VPVirginie Passet
Virginie Passet
AAAna S Almeida
Ana S Almeida
RTRégis Tournebize
Régis Tournebize
Klebsiella pneumoniae strains are pathogenic to animals and humans, in which they are both a frequent cause of nosocomial infections and a re-emerging cause of severe community-acquired infections. K. pneumoniae isolates of the capsular serotype K2 are among the most virulent. In order to identify novel putative virulence factors that may account for the severity of K2 infections, the genome sequence of the K2 reference strain Kp52.145 was determined and compared to two K1 and K2 strains of low virulence and to the reference strains MGH 78578 and NTUH-K2044.

25 October 2024 in Science
Verified
Journal Article
Closed access
MSManojit Mosur Swamynathan
Manojit Mosur Swamynathan
SKShan Kuang
Shan Kuang
KWKaitlin E. Watrud
Kaitlin E. Watrud
MDMary R. Doherty
Mary R. Doherty
CGCharlotte Gineste
Charlotte Gineste
LTLloyd C Trotman
Lloyd C Trotman
Men taking antioxidant vitamin E supplements have increased prostate cancer (PC) risk. However, whether pro-oxidants protect from PC remained unclear. In this work, we show that a pro-oxidant vitamin K precursor [menadione sodium bisulfite (MSB)] suppresses PC progression in mice, killing cells through an oxidative cell death: MSB antagonizes the essential class III phosphatidylinositol (PI) 3-kinase VPS34—the regulator of endosome identity and sorting—through oxidation of key cysteines, pointing to a redox checkpoint in sorting. Testing MSB in a myotubular myopathy model that is driven by loss of MTM1 —the phosphatase antagonist of VPS34—we show that dietary MSB improved muscle histology and function and extended life span. These findings enhance our understanding of pro-oxidant selectivity and show how definition of the pathways they impinge on can give rise to unexpected therapeutic opportunities.

15 July 2020 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
MFMiriam R. Fein
Miriam R. Fein
XHXue-Yan He
Xue-Yan He
AAAna S. Almeida
Ana S. Almeida
EBEmilis Bružas
Emilis Bružas
APArnaud Pommier
Arnaud Pommier
MEMikala Egeblad
Mikala Egeblad
C-C chemokine receptor type 2 (CCR2) is expressed on monocytes and facilitates their recruitment to tumors. Though breast cancer cells also express CCR2, its functions in these cells are unclear. We found that Ccr2 deletion in cancer cells led to reduced tumor growth and approximately twofold longer survival in an orthotopic, isograft breast cancer mouse model. Deletion of Ccr2 in cancer cells resulted in multiple alterations associated with better immune control: increased infiltration and activation of cytotoxic T lymphocytes (CTLs) and CD103+ cross-presenting dendritic cells (DCs), as well as up-regulation of MHC class I and down-regulation of checkpoint regulator PD-L1 on the cancer cells. Pharmacological or genetic targeting of CCR2 increased cancer cell sensitivity to CTLs and enabled the cancer cells to induce DC maturation toward the CD103+ subtype. Consistently, Ccr2−/− cancer cells did not induce immune suppression in Batf3−/− mice lacking CD103+ DCs. Our results establish that CCR2 signaling in cancer cells can orchestrate suppression of the immune response.